Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001380260 | SCV001578256 | pathogenic | not provided | 2023-06-30 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Arg249*) in the LMX1B gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in LMX1B are known to be pathogenic (PMID: 9590287, 15498463). This variant is present in population databases (rs121909492, gnomAD 0.003%). This premature translational stop signal has been observed in individual(s) with Nail-Patella Syndrome (PMID: 9837817). ClinVar contains an entry for this variant (Variation ID: 7010). For these reasons, this variant has been classified as Pathogenic. |
Gene |
RCV001380260 | SCV004034362 | pathogenic | not provided | 2023-09-08 | criteria provided, single submitter | clinical testing | Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; This variant is associated with the following publications: (PMID: 25525159, 34426522, 9837817) |
OMIM | RCV000007425 | SCV000027625 | pathogenic | Nail-patella syndrome | 1998-12-01 | no assertion criteria provided | literature only | |
Bioscientia Institut fuer Medizinische Diagnostik Gmb |
RCV000007425 | SCV000746071 | pathogenic | Nail-patella syndrome | 2017-09-18 | no assertion criteria provided | clinical testing |